From favorable histology to relapse: the clonal evolution of a wilms tumor

J Saliba, N Belsky, A Patel, K Thomas… - Pediatric and …, 2020 - journals.sagepub.com
Favorable histology (FH) Wilms tumor (WT) is one of the most curable of all human cancers,
yet a small minority of patients fail treatment. The underlying biological pathways that lead to …
被引用次数：4 相关文章

From Favorable Histology to Relapse: The Clonal Evolution of a Wilms Tumor

J Saliba, N Belsky, A Patel… - … : the official journal …, 2020 - pubmed.ncbi.nlm.nih.gov
Favorable histology (FH) Wilms tumor (WT) is one of the most curable of all human cancers,
yet a small minority of patients fail treatment. The underlying biological pathways that lead to …

From Favorable Histology to Relapse: The Clonal Evolution of a Wilms Tumor.

J Saliba, N Belsky, A Patel, K Thomas… - … Pathology: the Official …, 2019 - europepmc.org
Favorable histology (FH) Wilms tumor (WT) is one of the most curable of all human cancers,
yet a small minority of patients fail treatment. The underlying biological pathways that lead to …

From Favorable Histology to Relapse: The Clonal Evolution of a Wilms Tumor

J Saliba, N Belsky, A Patel… - Pediatric and …, 2020 - scholars.northwestern.edu
Favorable histology (FH) Wilms tumor (WT) is one of the most curable of all human cancers,
yet a small minority of patients fail treatment. The underlying biological pathways that lead to …

From Favorable Histology to Relapse: The Clonal Evolution of a Wilms Tumor

J Saliba, N Belsky, A Patel, K Thomas… - Pediatric and …, 2020 - profiles.wustl.edu
Favorable histology (FH) Wilms tumor (WT) is one of the most curable of all human cancers,
yet a small minority of patients fail treatment. The underlying biological pathways that lead to …
[PDF] academia.edu

[PDF][PDF] From Favorable Histology to Relapse: The Clonal Evolution of a Wilms Tumor

J Saliba, N Belsky, A Patel, K Thomas… - Pediatric and …, 2019 - academia.edu
Favorable histology (FH) Wilms tumor (WT) is one of the most curable of all human cancers,
yet a small minority of patients fail treatment. The underlying biological pathways that lead to …